Shots: Aronora to receive $6M upfront & $3M upon fulfillment of certain conditions. Xoma to get rights to royalties and 10% of milestone payments associated with five hematology assets from […]readmore
Tags : Royalty
Shots: Immunogen to receive $65M as total deal value and OMERS to get royalties on sales of Kadcyla In 2015, Immunogen & IRH collaborated for Kadcyla’s royalty for $200M, where […]readmore
Shots: Palvella will receive $10M as total deal value from Ligand, and will be responsible for PTX-022 development and commercialization. Ligand to get milestones and royalties on sales of PTX-022 The focus of […]readmore